MDT

88.85

+1.62%↑

VEEV

279.31

-1.23%↓

A

121.78

+3.12%↑

WBA

11.5

-0.26%↓

HQY

102.44

+1.94%↑

MDT

88.85

+1.62%↑

VEEV

279.31

-1.23%↓

A

121.78

+3.12%↑

WBA

11.5

-0.26%↓

HQY

102.44

+1.94%↑

MDT

88.85

+1.62%↑

VEEV

279.31

-1.23%↓

A

121.78

+3.12%↑

WBA

11.5

-0.26%↓

HQY

102.44

+1.94%↑

MDT

88.85

+1.62%↑

VEEV

279.31

-1.23%↓

A

121.78

+3.12%↑

WBA

11.5

-0.26%↓

HQY

102.44

+1.94%↑

MDT

88.85

+1.62%↑

VEEV

279.31

-1.23%↓

A

121.78

+3.12%↑

WBA

11.5

-0.26%↓

HQY

102.44

+1.94%↑

Search

China Pharma Holdings Inc

Open

1.62 -1.82

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.58

Max

1.68

Dividenden

By Dow Jones

Nächstes Ergebnis

12. Aug. 2025

China Pharma Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Juli 2025, 15:29 UTC

Wichtige Markttreiber

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

7. Juli 2025, 23:44 UTC

Market Talk

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

7. Juli 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Juli 2025, 23:41 UTC

Market Talk

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

7. Juli 2025, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

7. Juli 2025, 23:19 UTC

Market Talk

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

7. Juli 2025, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

7. Juli 2025, 22:20 UTC

Market Talk

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

7. Juli 2025, 21:34 UTC

Akquisitionen, Fusionen, Übernahmen

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

7. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Juli 2025, 20:45 UTC

Akquisitionen, Fusionen, Übernahmen

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7. Juli 2025, 20:16 UTC

Market Talk

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

7. Juli 2025, 19:37 UTC

Market Talk

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

7. Juli 2025, 19:12 UTC

Market Talk

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

7. Juli 2025, 18:33 UTC

Market Talk

Gold Flat as Investors Assess Market Direction -- Market Talk

7. Juli 2025, 18:27 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Juli 2025, 16:53 UTC

Ergebnisse

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

7. Juli 2025, 16:30 UTC

Market Talk

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

7. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. Juli 2025, 16:05 UTC

Akquisitionen, Fusionen, Übernahmen

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7. Juli 2025, 15:41 UTC

Market Talk

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

7. Juli 2025, 15:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

7. Juli 2025, 15:40 UTC

Market Talk

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

7. Juli 2025, 15:30 UTC

Market Talk

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

7. Juli 2025, 15:18 UTC

Market Talk

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

7. Juli 2025, 15:14 UTC

Akquisitionen, Fusionen, Übernahmen

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

7. Juli 2025, 15:00 UTC

Akquisitionen, Fusionen, Übernahmen

GSK Completes Acquisition of Efimosfermin

7. Juli 2025, 14:52 UTC

Market Talk

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

7. Juli 2025, 14:51 UTC

Market Talk

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

7. Juli 2025, 14:45 UTC

Market Talk

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Peer-Vergleich

Kursveränderung

China Pharma Holdings Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Finanzen

$